HIGHLIGHTS
- who: John Klier et al. from the Equine Clinic, Centre for Clinical Veterinary Medicine, Ludwig-Maximilians-University, Oberschleißheim, Germany have published the research: Inhalative Nanoparticulate CpG Immunotherapy in Severe Equine Asthma: An Innovative Therapeutic Concept and Potential Animal Model for Human Asthma Treatment, in the Journal: Animals 2022, x of /2022/
- what: Immunotherapy with CpG-GNP, independent of the causal antigens that may vary geographically and with different endo- and phenotypes, is an effective, allergen-independent, inhalative immunomodulatory therapy with a demonstrated clinical and immunological ongoing effect over at least eight weeks in horses . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.